Medtronic Approves Q2 FY2027 Dividend, Announces Q1 Earnings Release Date

Medtronic Approves Q2 FY2027 Dividend, Announces Q1 Earnings Release Date

Fri, August 28, 2026

Medtronic plc (NYSE: MDT) announced that its board of directors approved a cash dividend of $0.72 per ordinary share for the second quarter of its fiscal year 2027 during a meeting held on Thursday, August 20, 2026. The company also confirmed that it will report financial results for the first quarter of fiscal year 2027 on Tuesday, September 1, 2026.

Dividend Approval: Rewarding Shareholders

The $0.72 per-share dividend underscores Medtronic’s commitment to returning capital to shareholders. While the announcement does not indicate stock-market reaction explicitly, investors often view consistent dividend payouts as a positive signal of financial stability and confidence in ongoing cash flows.

Upcoming Q1 FY2027 Earnings Release

Medtronic confirmed that it will release its first-quarter financial results for fiscal year 2027 on September 1, 2026. This date gives analysts and investors an important marker to anticipate potential updates on revenue performance, margins, guidance, and progress across its key business segments.

Context and Outlook

These developments are part of Medtronic’s regular financial calendar. The dividend aligns with its shareholder distribution strategy, while the upcoming earnings report will offer insights into early fiscal year performance. Together, they provide signals investors can monitor, though no immediate stock-market reaction was verified in connection with these announcements.

What Investors Should Watch

  • The actual Q1 results on September 1—including revenue, EPS (GAAP and non-GAAP), segment performance, and management commentary.
  • Any accompanying guidance updates or strategic outlook offered with the earnings release.
  • Investor response to the dividend approval, particularly in terms of yield and perceived financial health.

As always, investors should await the actual financial disclosures before drawing connections between corporate announcements and stock-price performance. The dividend and earnings date are confirmed facts; any inferred market reaction should be supported by financial reporting following September 1.

Stock data reminder: Medtronic shares were trading at approximately $91.23 as of August 28, 2026, reflecting a 1.04% change that day.